Refractory pyoderma gangrenosum associated with rheumatoid arthritis successfully treated with upadacitinib. Comments on: "JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum".
Mayra Rabelo Dos SantosMayra IanhezBruno Nazeozeno RibeiroBoaventura Braz de QueirozHélio Amarante MiotPublished in: International journal of dermatology (2023)